SEC Form 4 · accession 0001562180-17-003887
Sage Therapeutics, Inc. · SAGE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Albert Robichaud
Officer — Chief Scientific Officer
Period of report
Dec 14, 2017
Accepted (ET)
Dec 14, 2017 · 6:51 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001597553
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2 | Dec 14, 2017 | S | 1,500 | $156.31 | D | 152,759 | D | |
| Common StockF3 | Dec 14, 2017 | S | 3,700 | $157.27 | D | 149,059 | D | |
| Common StockF4 | Dec 14, 2017 | S | 16,748 | $158.18 | D | 132,311 | D | |
| Common StockF5 | Dec 14, 2017 | S | 8,734 | $159.46 | D | 123,577 | D | |
| Common StockF6 | Dec 14, 2017 | S | 21,410 | $160.12 | D | 102,167 | D | |
| Common StockF6 | Dec 14, 2017 | S | 6,187 | $161.40 | D | 95,980 | D | |
| Common StockF7 | Dec 14, 2017 | S | 700 | $162.21 | D | 95,280 | D | |
| Common StockF8 | Dec 14, 2017 | S | 1,021 | $163.93 | D | 94,259 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The sales reported on this Form 4 were effected pursuant to a trading plan adopted pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.
- F2This transaction was executed in multiple trades at prices ranging from $155.81 USD to $156.72 USD. The price reported above reflects the weighted average sale price.
- F3This transaction was executed in multiple trades at prices ranging from $156.82 USD to $157.80 USD. The price reported above reflects the weighted average sale price.
- F4This transaction was executed in multiple trades at prices ranging from $157.83 USD to $158.81 USD. The price reported above reflects the weighted average sale price.
- F5This transaction was executed in multiple trades at prices ranging from $158.90 USD to $159.8901 USD. The price reported above reflects the weighted average sale price.
- F6This transaction was executed in multiple trades at prices ranging from $159.90 USD to $160.89 USD. The price reported above reflects the weighted average sale price.
- F7This transaction was executed in multiple trades at prices ranging from $162.01 USD to $162.45 USD. The price reported above reflects the weighted average sale price.
- F8This transaction was executed in multiple trades at prices ranging from $163.57 USD to $164.24 USD. The price reported above reflects the weighted average sale price.